GlaxoSmithKline Pakistan Ltd
KAR:GLAXO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline Pakistan Ltd
KAR:GLAXO
|
PK |
|
A
|
Aldeyra Therapeutics Inc
F:137
|
US |
|
F
|
FACC AG
SWB:1FC
|
AT |
|
N
|
Netcall PLC
F:NEW
|
UK |
|
L
|
Liberty Broadband Corp
NASDAQ:LBRDK
|
US |
|
Ibio Inc
F:0JV0
|
US |
|
O
|
OPKO Health Inc
F:XCY
|
US |
|
V
|
Vestas Wind Systems A/S
XHAN:VWSB
|
DK |
|
Conrad Asia Energy Ltd
F:3MD
|
ID |
|
First Phosphate Corp
F:KD0
|
CA |
|
Goldplat PLC
F:G7N
|
UK |
Wall St Price Targets
GLAXO Price Targets Summary
GlaxoSmithKline Pakistan Ltd
According to Wall Street analysts, the average 1-year price target for GLAXO is 548.25 PKR with a low forecast of 530.25 PKR and a high forecast of 577.5 PKR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLAXO's stock price target?
Price Target
548.25
PKR
According to Wall Street analysts, the average 1-year price target for GLAXO is 548.25 PKR with a low forecast of 530.25 PKR and a high forecast of 577.5 PKR.
What is the Revenue forecast for GlaxoSmithKline Pakistan Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 9%.
What is the Gross Profit forecast for GlaxoSmithKline Pakistan Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for GlaxoSmithKline Pakistan Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for GlaxoSmithKline Pakistan Ltd?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 3 years is 14%.
